Evidence map›Paper›PMID 29458998›Full record

ArticleBiological psychiatry2018

Role of Striatal Direct Pathway 2-Arachidonoylglycerol Signaling in Sociability and Repetitive Behavior.

Brian C Shonesy, Walker P Parrish, Hala K Haddad, Jason R Stephenson, Rita Báldi, Rebecca J Bluett, Christian R Marks, Samuel W Centanni, Oakleigh M Folkes, Keeley Spiess and 6 more

Abstract read
In one paragraph

Article in Biological psychiatry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Beyond dopamine: exploring endocannabinoids in Parkinson's disease.Ageing and neurodegenerative diseases · 2024
    Article
  6. Striatonigral direct pathway 2-arachidonoylglycerol contributes to ethanol effects on synaptic transmission and behavior.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Article
  7. Article
  8. Anandamide and 2-arachidonoylglycerol differentially modulate autistic-like traits in a genetic model of autism based on FMR1 deletion in rats.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Article
  9. Article
  10. Review
  11. Article
  12. Combinatorial approaches for treating neuropsychiatric social impairment.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2022
    Review
  13. Lipid-Based Molecules on Signaling Pathways in Autism Spectrum Disorder.International journal of molecular sciences · 2022
    Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Genes · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 1 country.

Brian C ShonesyDepartment of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee. Electronic address: brian.shonesy@vanderbilt.edu.
Walker P ParrishDepartment of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee.
Hala K HaddadDepartment of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee.
Jason R StephensonDepartment of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee.
Rita BáldiDepartment of Psychiatry, Vanderbilt University Medical Center, Nashville, Tennessee.
Rebecca J BluettDepartment of Psychiatry, Vanderbilt University Medical Center, Nashville, Tennessee.
Christian R MarksDepartment of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee.
Samuel W CentanniDepartment of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee.
Oakleigh M FolkesDepartment of Psychiatry, Vanderbilt University Medical Center, Nashville, Tennessee.
Keeley SpiessDepartment of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee.
Shana M AugustinLaboratory for Integrative Neuroscience, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland.
Ken MackieThe Gill Center and the Department of Psychological and Brain Sciences, Indiana University, Bloomington, Indiana.
David M LovingerLaboratory for Integrative Neuroscience, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland.
Danny G WinderDepartment of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee.
Sachin PatelDepartment of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee; Department of Psychiatry, Vanderbilt University Medical Center, Nashville, Tennessee.
Roger J ColbranDepartment of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee.
Vanderbilt University · USVanderbilt University Medical Center · USIndiana University Bloomington · USNational Institute on Alcohol Abuse and Alcoholism · USNational Institutes of Health · US

Funding

Corticostriatal mechanisms of action learning and habit formationZIAAA000416 · NIAAA · NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM · PI LOVINGER, DAVID M · 2009 to 2025
$25.2M
THE ROLE OF ENDOCANNABINOIDS AND THEIR RECEPTORS IN COLORECTAL CANCERP01CA077839 · NCI · VANDERBILT UNIVERSITY · PI YANG, PEIYING · 1999 to 2016
$17.8M
TRAINING IN PHARMACOLOGICAL SCIENCEST32GM007628 · NIGMS · VANDERBILT UNIVERSITY · PI BARNETT, JOEY VICTOR, KAVALALI, EGE T · 1985 to 2022
$11.2M
Vanderbilt/Meharry Initiative for Minority Student DvptR25GM062459 · NIGMS · VANDERBILT UNIVERSITY · PI VELEZ EDWARDS, DIGNA R · 2002 to 2020
$10.4M
Research Project: Sensory and Multisensory Contributions to AutismU54HD083211 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DYKENS, ELISABETH MAY · 2015 to 2019
$7.1M
Program in NeurogenomicsT32MH065215 · NIMH · VANDERBILT UNIVERSITY · PI ROGER J COLBRAN · 2002 to 2026
$6.4M
2-Arachidonoylglycerol signaling in anxiety, depression, and stress adaptationR01MH107435 · NIMH · VANDERBILT UNIVERSITY MEDICAL CENTER · PI PATEL, SACHIN · 2016 to 2025
$5.0M
CaMKII, endocannabinoids, synaptic plasticity and motor functionR01NS078291 · NINDS · VANDERBILT UNIVERSITY · PI COLBRAN, ROGER J · 2012 to 2016
$1.8M
Cannabinoid Modulation of Cell FunctionK05DA021696 · NIDA · TRUSTEES OF INDIANA UNIVERSITY · PI MACKIE, KENNETH · 2007 to 2017
$1.3M
Endocannabinoids in social and repetitive behavioral domainsK01MH107765 · NIMH · VANDERBILT UNIVERSITY · PI SHONESY, BRIAN C · 2015 to 2018
$454k
Acquisition of an AB Sciex Qtrap 6500 LC/MS/MS SystemS10OD017997 · OD · VANDERBILT UNIVERSITY · PI MARNETT, LAWRENCE J. · 2015 to 2015
$450k
2-Arachidonoylglycerol Signaling Relieves Stress-induced AnxietyF31MH106192 · NIMH · VANDERBILT UNIVERSITY · PI BLUETT, REBECCA J · 2015 to 2017
$90k
NCI NIH HHS P01 CA077839NICHD NIH HHS U54 HD083211NIDA NIH HHS K05 DA021696NIGMS NIH HHS R25 GM062459NIGMS NIH HHS T32 GM007628NIH HHS S10 OD017997NIMH NIH HHS F31 MH106192NIMH NIH HHS F31 MH109196NIMH NIH HHS K01 MH107765NIMH NIH HHS R01 MH107435NIMH NIH HHS T32 MH065215NINDS NIH HHS N01 NS002331NINDS NIH HHS R01 NS078291
6 · The paper itself

Abstract

backgroundEndocannabinoid signaling plays an important role in regulating synaptic transmission in the striatum, a brain region implicated as a central node of dysfunction in autism spectrum disorder. Deficits in signaling mediated by the endocannabinoid 2-arachidonoylglycerol (2-AG) have been reported in mouse models of autism spectrum disorder, but a causal role for striatal 2-AG deficiency in phenotypes relevant to autism spectrum disorder has not been explored.

methodsUsing conditional knockout mice, we examined the electrophysiological, biochemical, and behavioral effects of 2-AG deficiency by deleting its primary synthetic enzyme, diacylglycerol lipase α (DGLα), from dopamine D

resultsTargeted deletion of DGLα from direct-pathway MSNs caused deficits in social interaction, excessive grooming, and decreased exploration of a novel environment. In contrast, deletion from indirect-pathway MSNs had no effect on any measure of behavior examined. Loss of 2-AG in direct-pathway MSNs also led to increased glutamatergic drive, which is consistent with a loss of retrograde feedback inhibition. Subregional DGLα deletion from the dorsal striatum produced deficits in social interaction, whereas deletion from the ventral striatum resulted in repetitive grooming.

conclusionsThese data suggest a role for 2-AG deficiency in social deficits and repetitive behavior, and they demonstrate a key role for 2-AG in regulating striatal direct-pathway MSNs.

Indexed as

Social BehaviorAnimalsArachidonic AcidsAutism Spectrum DisorderCorpus StriatumEndocannabinoidsGlyceridesMiceMice, KnockoutReceptor, Adenosine A2AReceptors, Dopamine D1Signal TransductionSynaptic TransmissionArachidonic AcidsEndocannabinoidsGlyceridesglyceryl 2-arachidonateReceptor, Adenosine A2AReceptors, Dopamine D12-ArachindonoylglycerolAutism spectrum disorderDiacylglycerol lipaseEndocannabinoidNucleus accumbensStriatum

Identifiers

PMID29458998
PMCPMC6023784
OpenAlexW2776985001

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.